Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Hematology
•
General Rheumatology
•
Dermatology
•
Pediatric Rheumatology
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
Related Questions
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
How would you approach management of an elderly patient with known mantle cell lymphoma and new diagnosis of cryoglobulinemic vasculitis with mild skin involvement, fatigue, arthralgias but no other major organ involvement?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
Can lupus anticoagulant be positive despite a normal aPTT?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
Can you see false positive autoimmune serologies in patients with a history of stem cell transplant and chronic graft vs host disease?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?
Do you perform genetic testing when patients have persistent hypogammaglobulinemia after rituximab therapy?
For patients with SLE, is there an ANC level for which you would hold or adjust hydroxychloroquine in an asymptomatic patient?
